# Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Gastric Carcinomatosis. Phase II Randomized Study

> **NCT04065139** · PHASE2 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 66 (actual)

## Conditions studied

- Gastric Adenocarcinoma
- Cancer Metastatic
- Chemotherapy Effect

## Interventions

- **DRUG:** Pressurized intraperitoneal aerosol chemotherapy (PIPAC)
- **DRUG:** Standard chemotherapy

## Key facts

- **NCT ID:** NCT04065139
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-11
- **Primary completion:** 2024-03-02
- **Final completion:** 2024-03-02
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04065139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04065139, "Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Gastric Carcinomatosis. Phase II Randomized Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04065139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*